Scale | T1 (pre-intervention) | T2 (post-intervention) | T3 (8-month follow-up) | p-valuea | p-valueb T1–T2 | p-valueb T1–T3 |
---|---|---|---|---|---|---|
CD-RISC 10 | 20.4 (19.2–21.6) | 30.6 (29.8–31.4) | 20.7 (19.5–22.0) | < 0.001 | < 0.001 | 0.665 |
Schwarzer’s General Self-Efficacy | 26.5 (25.2–27.7) | 33.6 (32.9–34.3) | 27.2 (26.1–28.3) | < 0.001 | < 0.001 | 0.311 |
Patient Health Questionnaire (PHQ-9) | 9.0 (8.0–10.0) | 1.5 (0.7–2.3) | 2.7 (2.0–3.3) | < 0.001 | < 0.001 | < 0.001 |
Generalised Anxiety Disorder (GAD-7) | 8.0 (7.1–8.9) | 0.7 (0.3–1.2) | 2.8 (2.3–3.4) | < 0.001 | < 0.001 | < 0.001 |
Gender attitudes scale | 22.0 (20.9–23.1) | 26.5 (26.1–26.8) | 25.6 (25.0–26.2) | < 0.001 | < 0.001 | < 0.001 |